GeneDx Holdings Corp. (WGS) Market Cap & Valuation Ratios
GeneDx Holdings Corp. (WGS) has a market cap of $1.7B and a price-to-sales ratio of 3.7, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
WGSGeneDx Holdings Corp.Follow WGS — free
—
Price chart with a free account
- Market cap
- 1.7B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 26 Oct, in 2 days
Peers
diagnostics & research · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| WGS | 1.7 | — | 3.6 | — | -4.5% | +25% | -20% | -35% |
| ADPT | 4.1 | — | 13.2 | — | -0.6% | +50% | -12% | -13% |
| VCYT | 3.9 | 34.2 | 6.3 | 28.1 | 4.3% | +17% | 19% | 10% |
| CDNA | 3.6 | 33.4 | 7.0 | 26.2 | 1.0% | +34% | 24% | 67% |
| NEO | 2.1 | — | 3.1 | — | -0.3% | +11% | -9% | -7% |
| PSNL | 1.7 | — | 21.2 | — | -6.0% | -13% | -164% | -82% |
| OPK | 1.2 | — | 2.1 | 30.5 | -11.0% | -11% | -8% | -4% |
| LMRI | 1.1 | — | — | — | — | — | 9% | — |
| CSTL | 1.0 | — | 2.1 | — | -0.0% | +3% | -9% | -8% |
| MYGN | 0.6 | — | 0.7 | — | -1.3% | -3% | -12% | -29% |
| FLGT | 0.6 | — | 0.9 | — | — | +7% | -38% | -12% |
| Median of these 10 | 33.8 | 3.1 | 28.1 | -0.5% | +7% | -9% | -8% |
; EV/Sales 3.6 vs. 3.1.
Growth vs. price
each dot a company · hover or tap for valuesGeneDx Holdings Corp. — questions
- What is GeneDx Holdings Corp.'s market cap?
- $1.7B.
- What is GeneDx Holdings Corp.'s price-to-sales ratio?
- 3.7.
Every figure on this page comes from GeneDx Holdings Corp.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.